Company Search:
Advanced Search
Sponsored Links
Dicerna Pharmaceuticals Inc Company Snapshot
Dicerna Pharmaceuticals Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Dicerna Pharmaceuticals Inc with three other companies in this sector in the United States: Intra-Cellular Therapies Inc (2016 sales of $330,702.00 of which 100% was Pharmaceutical), Revance Therapeutics Inc ($300,000.00 of which 100% was Botulinum Toxin Products), and Kazia Therapeutics Ltd ($294,977.08 ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Dicerna Pharmaceuticals Inc
  Stock Performance Chart for Dicerna Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 8.42
(Figures in U.S. Dollars)
1 Week -3.9%   13 Weeks 10.9%  
4 Weeks 50.9%   52 Weeks 177.9%  
Dicerna Pharmaceuticals Inc Key Data:
  Ticker: DRNA Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 295,000
(Year Ending Jan 2017).
Employees: 47
  Currency: U.S. Dollars Market Cap: 175,544,395
  Fiscal Yr Ends: December Shares Outstanding: 20,848,503
  Share Type: Common Closely Held Shares: 336,814
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.